Tributyltin Increases the Expression of Apoptosis- and Adipogenesis-related Genes in Rat Ovaries

Overview

Journal Clin Exp Reprod Med

Date 2012 May 8

PMID 22563546

Citations 5

Authors

Hyojin Lee

Sojeong Lim

Sujin Yun

Ayoung Yoon

Gayoung Park

Hyunwon Yang

Affiliations

Soon will be listed here.

Abstract

Objective: Tributyltin (TBT), an endocrine disrupting chemical, has been reported to decrease ovarian function by causing apoptosis in the ovary, but the mechanism is not fully understood. Therefore, we examined whether TBT increases the expression of adipogenesis-related genes in the ovary and the increased expression of these genes is associated with apoptosis induction.

Methods: Three-week-old Sprague-Dawley rats were orally administered TBT (1 or 10 mg/kg body weight) or sesame oil as a control for 7 days. The ovaries were obtained and weighed on day 8, and then they were fixed for terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) or frozen for RNA extraction. Using the total RNA of the ovaries, adipogenesis- and apoptosis-related genes were analyzed by real-time polymerase chain reaction (PCR).

Results: The ovarian weight was significantly decreased in rats administered 10 mg/kg TBT compared to that in control rats. As determined by the TUNEL assay, the number of apoptotic follicles in ovary was significantly increased in rats administered 10 mg/kg TBT. The real-time PCR results showed that the expression of adipogenesis-related genes such as PPARγ, aP2, CD36, and PEPCK was increased after TBT administration. In addition, apoptosis-related genes such as TNFα and TNFR1 were expressed more in the TBT-administered rats compared with the control rats.

Conclusion: The present study demonstrates that TBT induces the expression of adipogenesis- and apoptosis-related genes in the ovary leading to apoptosis in the ovarian follicles. These results suggest that the increased expression of adipogenesis-related genes in the ovary by TBT exposure might induce apoptosis resulting in a loss of ovarian function.

Citing Articles

Organotin Antifouling Compounds and Sex-Steroid Nuclear Receptor Perturbation: Some Structural Insights.

Beg M, Beg M, Zargar U, Sheikh I, Bajouh O, Abuzenadah A Toxics. 2023; 11(1).

PMID: 36668751 PMC: 9864748. DOI: 10.3390/toxics11010025.

Endocrine disruptor chemicals, adipokines and reproductive functions.

Kurowska P, Mlyczynska E, Dawid M, Respekta N, Pich K, Serra L Endocrine. 2022; 78(2):205-218.

PMID: 35476178 DOI: 10.1007/s12020-022-03061-4.

Multispecies study: low-dose tributyltin impairs ovarian theca cell cholesterol homeostasis through the RXR pathway in five mammalian species including humans.

Pu Y, Pearl S, Gingrich J, Jing J, Martin D, Murga-Zamalloa C Arch Toxicol. 2019; 93(6):1665-1677.

PMID: 31006824 PMC: 6625865. DOI: 10.1007/s00204-019-02449-y.

Organotin Exposure and Vertebrate Reproduction: A Review.

de Araujo J, Lang Podratz P, Merlo E, Sarmento I, Santos da Costa C, Nino O Front Endocrinol (Lausanne). 2018; 9:64.

PMID: 29545775 PMC: 5838000. DOI: 10.3389/fendo.2018.00064.

EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.

Gore A, Chappell V, Fenton S, Flaws J, Nadal A, Prins G Endocr Rev. 2015; 36(6):E1-E150.

PMID: 26544531 PMC: 4702494. DOI: 10.1210/er.2015-1010.

References

le Maire A, Grimaldi M, Roecklin D, Dagnino S, Vivat-Hannah V, Balaguer P . Activation of RXR-PPAR heterodimers by organotin environmental endocrine disruptors. EMBO Rep. 2009; 10(4):367-73. PMC: 2672886. DOI: 10.1038/embor.2009.8. View

Appel K . Organotin compounds: toxicokinetic aspects. Drug Metab Rev. 2004; 36(3-4):763-86. DOI: 10.1081/dmr-200033490. View

Ogata R, Omura M, Shimasaki Y, Kubo K, Oshima Y, Aou S . Two-generation reproductive toxicity study of tributyltin chloride in female rats. J Toxicol Environ Health A. 2001; 63(2):127-44. DOI: 10.1080/15287390151126469. View

Chawla A, Schwarz E, Dimaculangan D, Lazar M . Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology. 1994; 135(2):798-800. DOI: 10.1210/endo.135.2.8033830. View

Boyer I . Toxicity of dibutyltin, tributyltin and other organotin compounds to humans and to experimental animals. Toxicology. 1989; 55(3):253-98. DOI: 10.1016/0300-483x(89)90018-8. View

McVey M, Cooke G . Inhibition of rat testis microsomal 3beta-hydroxysteroid dehydrogenase activity by tributyltin. J Steroid Biochem Mol Biol. 2003; 86(1):99-105. DOI: 10.1016/s0960-0760(03)00256-5. View

Kirchner S, Kieu T, Chow C, Casey S, Blumberg B . Prenatal exposure to the environmental obesogen tributyltin predisposes multipotent stem cells to become adipocytes. Mol Endocrinol. 2010; 24(3):526-39. PMC: 2840805. DOI: 10.1210/me.2009-0261. View

Saitoh M, Yanase T, Morinaga H, Tanabe M, Mu Y, Nishi Y . Tributyltin or triphenyltin inhibits aromatase activity in the human granulosa-like tumor cell line KGN. Biochem Biophys Res Commun. 2001; 289(1):198-204. DOI: 10.1006/bbrc.2001.5952. View

Cangialosi M, Puccia E, Mazzola A, Mansueto V, Arukwe A . Screening of ovarian steroidogenic pathway in Ciona intestinalis and its modulation after tributyltin exposure. Toxicol Appl Pharmacol. 2010; 245(1):124-33. DOI: 10.1016/j.taap.2010.03.001. View

10.

Shao D, Lazar M . Peroxisome proliferator activated receptor gamma, CCAAT/enhancer-binding protein alpha, and cell cycle status regulate the commitment to adipocyte differentiation. J Biol Chem. 1997; 272(34):21473-8. DOI: 10.1074/jbc.272.34.21473. View

11.

Sharov A, Falco G, Piao Y, Poosala S, Becker K, Zonderman A . Effects of aging and calorie restriction on the global gene expression profiles of mouse testis and ovary. BMC Biol. 2008; 6:24. PMC: 2426674. DOI: 10.1186/1741-7007-6-24. View

12.

Schneider P, Tschopp J . Apoptosis induced by death receptors. Pharm Acta Helv. 2000; 74(2-3):281-6. DOI: 10.1016/s0031-6865(99)00038-2. View

13.

Michalik L, Auwerx J, Berger J, Chatterjee V, Glass C, Gonzalez F . International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev. 2006; 58(4):726-41. DOI: 10.1124/pr.58.4.5. View

14.

Minge C, Bennett B, Norman R, Robker R . Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reverses the adverse effects of diet-induced obesity on oocyte quality. Endocrinology. 2008; 149(5):2646-56. DOI: 10.1210/en.2007-1570. View

15.

Komar C, Curry Jr T . Inverse relationship between the expression of messenger ribonucleic acid for peroxisome proliferator-activated receptor gamma and P450 side chain cleavage in the rat ovary. Biol Reprod. 2003; 69(2):549-55. DOI: 10.1095/biolreprod.102.012831. View

16.

Mu Y, Yanase T, Nishi Y, Takayanagi R, Goto K, Nawata H . Combined treatment with specific ligands for PPARgamma:RXR nuclear receptor system markedly inhibits the expression of cytochrome P450arom in human granulosa cancer cells. Mol Cell Endocrinol. 2001; 181(1-2):239-48. DOI: 10.1016/s0303-7207(00)00457-3. View

17.

Philbert M, Billingsley M, Reuhl K . Mechanisms of injury in the central nervous system. Toxicol Pathol. 2000; 28(1):43-53. DOI: 10.1177/019262330002800107. View

18.

Ashkenazi A, Dixit V . Apoptosis control by death and decoy receptors. Curr Opin Cell Biol. 1999; 11(2):255-60. DOI: 10.1016/s0955-0674(99)80034-9. View

19.

Yamasaki K, Sawaki M, Takatsuki M . Immature rat uterotrophic assay of bisphenol A. Environ Health Perspect. 2001; 108(12):1147-50. PMC: 1240195. DOI: 10.1289/ehp.001081147. View

20.

Carfi M, Croera C, Ferrario D, Campi V, Bowe G, Pieters R . TBTC induces adipocyte differentiation in human bone marrow long term culture. Toxicology. 2008; 249(1):11-8. DOI: 10.1016/j.tox.2008.03.025. View